192 filings
Page 3 of 10
8-K
eym0wlidwvdqkt
16 Sep 21
Departure of Directors or Certain Officers
9:17pm
8-K
dm3cw7rmce
15 Sep 21
Entry into a Material Definitive Agreement
4:07pm
8-K
9dr5m9
14 Sep 21
Departure of Directors or Certain Officers
5:29pm
8-K
xhsfa r721h9xg
7 Sep 21
Other Events
5:28pm
8-K
ve165z1unn
16 Aug 21
Other Events
4:18pm
8-K
005c7spn2o2o
29 Jul 21
Travere Therapeutics Reports Second Quarter 2021 Financial Results
4:04pm
8-K
jgoxe5n889a373tj
10 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:17pm
8-K
kw83fjejf
25 May 21
Other Events
4:44pm
8-K
r5l2umqpnaw
19 May 21
Departure of Directors or Certain Officers
12:00am
8-K
atnd2pivhi33t9v
6 May 21
Travere Therapeutics Reports First Quarter 2021 Financial Results
4:11pm
8-K
y94kxson5v1uraxuo ad
1 Mar 21
Travere Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
4:14pm
8-K
y3ybd9 tfp8q
12 Feb 21
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:46pm
8-K
tgu3a5dvxyb6
10 Feb 21
Results of Operations and Financial Condition
5:29pm
8-K
f3laontp1kv
2 Feb 21
Other Events
4:10pm
8-K
2ka8p86m
11 Jan 21
Travere Therapeutics Provides Corporate Update and 2021 Outlook
7:00am
8-K
4vv fd2ib
18 Nov 20
Completion of Acquisition or Disposition of Assets
5:18pm
8-K/A
j2kqrlf 9x2q
18 Nov 20
Other Events
5:16pm
8-K
p6gpb4s d2
16 Nov 20
Amendments to Articles of Incorporation or Bylaws
4:04pm
8-K
n1golb 8sz4
12 Nov 20
Other Events
4:08pm
8-K
837cy
5 Nov 20
Retrophin Reports Third Quarter 2020 Financial Results
4:14pm